OPKO HEALTH INC. - COMMON STOCK

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

09 Jan 2025 10:45:00 By Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

07 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

12 Dec 2024 10:21:35 By NetDania Notify

OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

20 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

07 Nov 2024 15:05:11 By Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

29 Oct 2024 15:05:00 By Nasdaq GlobeNewswire

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

07 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development

23 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

17 Sep 2024 10:54:13 By NetDania Notify

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

07 Aug 2024 15:06:35 By Nasdaq GlobeNewswire

OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024

01 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

OPKO Health Announces $100 Million Share Repurchase Program

18 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments

17 Jul 2024 15:14:57 By Nasdaq GlobeNewswire

OPKO Health to Participate in the Jefferies Global Healthcare Conference

31 May 2024 09:49:15 By Nasdaq GlobeNewswire

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

07 May 2024 15:05:00 By Nasdaq GlobeNewswire

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

03 May 2024 07:00:00 By Nasdaq GlobeNewswire

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

05 Mar 2024 07:52:22 By Nasdaq GlobeNewswire

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

27 Feb 2024 15:05:00 By Nasdaq GlobeNewswire

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

22 Feb 2024 15:05:00 By Nasdaq GlobeNewswire

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes

09 Jan 2024 15:05:28 By Nasdaq GlobeNewswire